Global Depression Drugs Market 2015 - Market Size, Share, Growth & Opportunities

1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Global Depression Drugs Market 2015-2019 Growth,
Global Share, Industry Overview, Analysis, Trends
Opportunities and Forecast
2
Description
Report Overview
About depression drugs According to the WHO,
depression is a common mental disorder that
contributes significantly to the global burden of
disease. It affects people across communities
worldwide. It is characterized by sadness, loss
of interest or pleasure, feelings of guilt or low
self-worth, disturbed sleep or appetite, feelings
of tiredness, and poor concentration. Depression
can be roughly categorized into six different
types. According to a 2012 estimate by the WHO,
about 3,000 suicides take place each day,
resulting in more than a million deaths each
year. Depression can be recurrent and can be
severely debilitating. Patients with mild
depression can be treated with medications, but
in cases of moderate or severe depression, the
patient needs both medication and professional
psychotherapy in the form of counseling. The
global depression drugs market to grow at a CAGR
of 5.25 over the period 2014-2019.   Read more
details at http//www.bigmarketresearch.com/globa
l-depression-drugs-2015-2019-market
3
Key Benefits
Summery
Global Depression Drugs Market report covers the
present scenario and the growth prospects of the
global depression drugs market for the period
2015-2019. To calculate the market size, the
report considers revenue generated from the sales
of various drugs used for the treatment of
depression. The global depression drugs market is
segmented based on the mechanism of action of the
drugs used to treat depression, as mentioned
below Tricyclic antidepressants
Serotonin-norepinephrine reuptake inhibitors
Selective serotonin reuptake inhibitors
Monoamine oxidase inhibitors Others   Global
Depression Drugs Market 2015-2019, has been
prepared based on an in-depth market analysis
with inputs from industry experts. The report
covers the Americas, EMEA, and APAC it also
covers the market landscape and its growth
prospects in the coming years. The report also
includes a discussion of the key vendors
operating in this market.
4
Key Audiences
Key regions Americas APAC EMEA  Key
vendors Actavis Bristol-Myers Squibb Eli
Lilly GlaxoSmithKline  Other prominent vendors
Abbott Laboratories Addex Therapeutics
Alkermes AstraZeneca Aurobindo Pharma
Avanir Pharmaceuticals Cerecor Chugai
Pharmaceutical
5
Table Of Contents
Market Trends
Market driver Rise in patient population For
a full, detailed list, view our report   Market
challenge Threat of expiry of patents For a
full, detailed list, view our report   Market
trend Growing public awareness For a full,
detailed list, view our report Enquire About
Report http//www.bigmarketresearch.com/report-en
quiry/250594
6
Get Full Information At http//www.bigmarketrese
arch.com/global-depression-drugs-2015-2019-market